Examples of using Rasitrio in English and their translations into Polish
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Rasitrio was associated with a significant reduction in plasma renin activity(PRA)(-34%)
Studies also showed that the active substances in Rasitrio are absorbed in the body in the same way as the active substances when given as separate tablets.
Very limited efficacy and safety data are available on the use of Rasitrio in patients aged 75 years or older.
using machines it must be borne in mind that dizziness or drowsiness may occasionally occur when taking Rasitrio.
over, are more susceptible to hypotension-related adverse reactions following treatment with Rasitrio see sections 4.2,
What Rasitrio is and what it is used for What Rasitrio is.
Due to hydrochlorothiazide contained in Rasitrio, if you drink alcohol while on treatment with this medicine, you may have an increased feeling of dizziness on standing up,
Rasitrio combines three antihypertensive active substances with complementary mechanisms to control blood pressure in patients with essential hypertension: aliskiren belongs to
Rasitrio is not recommended in early pregnancy,
Rasitrio is used to treat high blood pressure in adult patients who have their blood pressure already controlled by aliskiren,
Rasitrio is indicated for the treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of aliskiren,
Rasitrio must not be used in people who are hypersensitive(allergic)
The concomitant use of Rasitrio with angiotensin II receptor blockers(ARB)
if you have impaired kidney function, your doctor will carefully consider whether Rasitrio is suitable for you and may wish to monitor you carefully.
If hypokalaemia develops during hydrochlorothiazide therapy Rasitrio should be discontinued until stable correction of the potassium balance.
In patients≥65 years the incidence was 10.2% with Rasitrio versus up to 5.4% with dual combinations.
In case severe or rapid hyponatraemia develops during Rasitrio therapy, the treatment should be discontinued until normalisation of natraemia.
There is no experience regarding the administration of Rasitrio in patients who have recently undergone kidney transplantation,
The incidence of any adverse reactions potentially related to hypotension in a short-term controlled study was 4.9% with Rasitrio versus up to 3.7% with dual combinations.
The adverse reactions previously reported with one of the individual components of Rasitrio(aliskiren, amlodipine and hydrochlorothiazide)